Ireland· IE-PA-PPA0465/428/001
MOVIPREP, powder for oral solution
A macrogol, kombinationen product containing sodium ascorbate + ascorbic acid + potassium chloride + sodium chloride, registered in Ireland by PCO Manufacturing Ltd.. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Macrogol, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC A06AD65 (macrogol, kombinationen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Macrogol, kombinationen · ATC A06AD65
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Sodium ascorbate + Ascorbic acid + Potassium chloride + Sodium chloride
- Manufacturer
- PCO Manufacturing Ltd.
- Country
- Ireland (IE)
- ATC code
- A06AD65
- ATC class
- Macrogol, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPPA0465/428/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
449 interactions on record for macrogol, kombinationen.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Macrogol, kombinationen · interactions on record
449 records
- 37 severe
- 411 moderate
- 1 minor
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- ProcainamideC01BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A06AD65
Macrogol, kombinationen, as other registers publish it.
- NorwayAbdominOrifarm Healthcare A/S
- NorwayAbdominOrifarm Healthcare A/S
- DenmarkAbdomin CitrusOrifarm Healthcare A/S
- DenmarkAbdomin Junior NeutralOrifarm Healthcare A/S
- DenmarkAbdomin NeutralOrifarm Healthcare A/S
- PolandAuroGoAurovitas Pharma Polska Sp. z o.o.
- NetherlandsBENLAXID 13,7 g poeder voor drankItalfarmaco, S.A.
- NetherlandsBENLAXID 6,9 g poeder voor drankItalfarmaco, S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3f0e182-c632-4ce2-91cb-15f576566b32 GET /v1/drugs/b3f0e182-c632-4ce2-91cb-15f576566b32?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for oral solution",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A06AD",
"A06AD65"
],
"strength": null,
"pa_number": "PPA0465/428/001",
"substances": [
"Sodium ascorbate",
"Ascorbic acid",
"Potassium chloride",
"Sodium chloride",
"Sodium sulphate anhydrous",
"Macrogol 3350"
],
"legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
"market_info": "Unknown",
"authorised_at": "13/04/2017",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about macrogol, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.